MOORE JOHN R (CIK 1191702) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy EWTX (5,781 shares), Buy EWTX (6,718 shares), Sell EWTX (2,439 shares), Sell EWTX (59 shares), Sell EWTX (99 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Buy | 5,781 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Buy | 6,718 | $0 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Sell | 2,439 | $106,848 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Sell | 59 | $2,620 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Sell | 99 | $4,406 |
| 2026-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Sell | 2,419 | $105,949 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Buy | 5,781 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Sell | 2,098 | $28,092 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Buy | 5,209 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | General Counsel | Sell | 1,930 | $31,748 |
Source: SEC Form 4 filings · as of 2026-08-14